RankingsPricing
  1. US-listed companies
  2. enVVeno Medical Corp

enVVeno Medical CorpNVNO

Market cap
$3.23M
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023
Selling, general and administrative expenses655111512
Research and development expenses12461014
Research and development expenses12461014
Selling, general and administrative expenses655111512
Loss from Operations-7,854,785-7,675,312-9,135,126-16,892,503-25-25
Gain on extinguishment of note payable1--312,700--
Realized gain from sales of trading securities-----1
Realized gain from sales of trading securities----0-
Unrealized loss from Investments----00
Unrealized gain from trading securities----0-
Interest income-----0
Interest income, net--49,915-3,73918,7090-
Total Other Income5-49,915360364,68102
Other income---33,272--
Total Other (Income) Expense5-49,915360364,68102
Net Loss-13,042,709-7,625,397-9,135,486-16,527,822-25-24
Net Loss Per Basic Common Share:-----2.2-1.91
Net Loss-13,042,709-7,625,397-9,135,486-16,527,822-25-24
Net Loss Per Diluted Common Share:------1.91
Net Loss Per Basic Common Share:-----2.2-1.91